Category
•
John Fauber of the Milwaukee Journal Sentinel reports on outside authors of drug company-funded studies who do not have access…

•
At ProPublica, Joaquin Sapien tells the story of how Louisiana Republican Sen. David Vitter successfully obstructed the FDA’s attempts to…

•
Bloggers and online journalists (Health Care Renewal, the nytpicker, Business Insider) have noticed that Princeton health economist Uwe Reinhardt, who…

•
In recent days, news coverage has detailed how a freelance health journalist was hired by a private investigative firm to…

•
Crikey.com, a news Web site based in Melbourne, Australia, calls our attention to some recent reporting about Mabthera, a drug…

•
Pharmaceutical companies are turning to doctors in private practice to promote their products as universities have developed conflict-of-interest policies that…

•
Sen. Chuck Grassley, the prolific writer of public letters who often assumes the mantle of health consumer advocate, is at…

A Syracuse University professor charged with reforming health insurance reimbursements gave up her position on an insurance company’s board on…

•
Records and interviews show that “Three California officials who oversee billions of dollars in Medi-Cal prescription drug spending have failed…

•
The Wall Street Journal‘s Jeanne Whalen writes that a recent string of charges against drug companies, including heavyweights like Pfizer,…
